First National Bank of Omaha bought a new stake in Humana Inc. (NYSE:HUM – Free Report) during the second quarter, Holdings Channel reports. The institutional investor bought 2,766 shares of the insurance provider’s stock, valued at approximately $1,099,000.
Several other institutional investors have also bought and sold shares of HUM. Vanguard Group Inc. raised its position in Humana by 0.7% in the 4th quarter. Vanguard Group Inc. now owns 14,261,860 shares of the insurance provider’s stock valued at $3,652,890,000 after buying an additional 106,030 shares during the last quarter. BlackRock Inc. purchased a new position in Humana during the 2nd quarter worth $4,138,160,000. Capital International Investors grew its stake in shares of Humana by 113.9% in the 4th quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock worth $1,490,239,000 after acquiring an additional 3,097,571 shares in the last quarter. Pzena Investment Management LLC raised its holdings in shares of Humana by 34.3% in the first quarter. Pzena Investment Management LLC now owns 5,470,982 shares of the insurance provider’s stock valued at $948,614,000 after purchasing an additional 1,398,774 shares during the last quarter. Finally, State Street Corp lifted its position in shares of Humana by 1.8% during the fourth quarter. State Street Corp now owns 5,462,549 shares of the insurance provider’s stock valued at $1,403,877,000 after purchasing an additional 97,211 shares in the last quarter. Institutional investors own 92.38% of the company’s stock.
Wall Street Analysts Forecast Growth
HUM has been the topic of several analyst reports. Truist Financial boosted their price target on shares of Humana from $320.00 to $415.00 and gave the stock a “hold” rating in a report on Tuesday, July 14th. Wolfe Research upgraded Humana from a “peer perform” rating to an “outperform” rating in a research note on Thursday, July 30th. Raymond James Financial lowered Humana from an “outperform” rating to a “market perform” rating in a report on Thursday, July 30th. Evercore upgraded Humana from an “in-line” rating to an “outperform” rating and set a $480.00 price target on the stock in a report on Wednesday, July 29th. Finally, Guggenheim boosted their price objective on Humana from $269.00 to $471.00 and gave the stock a “buy” rating in a research report on Thursday, July 30th. Fourteen equities research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $395.22.
Humana Price Performance
Shares of NYSE HUM opened at $377.18 on Thursday. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.62. The stock has a fifty day simple moving average of $383.16 and a two-hundred day simple moving average of $279.59. Humana Inc. has a 1-year low of $163.11 and a 1-year high of $428.88. The firm has a market cap of $45.29 billion, a price-to-earnings ratio of 35.68, a price-to-earnings-growth ratio of 2.18 and a beta of 0.72.
Humana (NYSE:HUM – Get Free Report) last issued its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.27 by $0.34. Humana had a return on equity of 11.20% and a net margin of 0.88%.The firm had revenue of $40.89 billion for the quarter, compared to analyst estimates of $40.58 billion. During the same period in the previous year, the company posted $6.27 earnings per share. The business’s revenue was up 26.2% on a year-over-year basis. Analysts anticipate that Humana Inc. will post 9.08 earnings per share for the current year.
About Humana
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Recommended Stories
- Five stocks we like better than Humana
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
